Synthesis, characterization, and remarkable biological properties of cyclodextrins bearing guanidinoalkylamino and aminoalkylamino groups on their primary side was written by Mourtzis, Nikolaos;Paravatou, Maria;Mavridis, Irene M.;Roberts, Michael L.;Yannakopoulou, Konstantina. And the article was included in Chemistry – A European Journal in 2008.HPLC of Formula: 53784-83-1 This article mentions the following:
The introduction of aminoalkylamino and guanidinoalkylamino substituents on the primary side of β- and γ-cyclodextrin (CDs) resulted in a series of novel compounds that were extensively characterized by NMR spectroscopy and mass spectrometry. Bromination of the primary side of β- and γ-CD, and reaction with neat alkylene diamines at a pressure of 7 atm afforded aminoalkylamino derivatives that were then guanylated at the primary amino group to give the corresponding guanidinoalkylamino-CDs. These compounds are water soluble and display pKa values that allow them to be mostly protonated at neutral pH; for example, pKa1 â?.4 and pKa2 â?.5 for the aminoethylamino-β-CD and pKa1 â?.8 and pKa2 â?1.0 for the guanidinoethylamino-β-CD. The title CDs are rigid, cyclic α-
Heptakis(6-Bromo-6-Deoxy)-β-Cyclodextrin (cas: 53784-83-1) belongs to organobromine compounds. Bromo compounds are employed in a variety of metal-catalyzed coupling reactions. They are also ideal candidates for the synthesis of Grignard reagents that have wide-applicability in organic synthesis. In the pharmaceutical industry organo bromine derivatives are used as sedatives, vasodilators, antiseptic agents, and anticancer agents.HPLC of Formula: 53784-83-1
Referemce:
Bromide – Wikipedia,
bromide – Wiktionary